Home > Insider Trading > Filing (0000899243-22-019018)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1783328	Tscan Therapeutics Inc.	TCRX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1251553	P David Southwell	C/O Tscan Therapeutics, Inc. 830 Winter Street Waltham MA 02451	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Voting Common Stock	Acquisiton	2022-05-18	15,000	$3.62	161,569	No	4	P	Direct
Voting Common Stock	Acquisiton	2022-05-18	10,000	$3.55	171,569	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $3.379 to $3.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $3.45 to $3.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote.